STAT3 and amyloidosis: First, we demonstrate that broad STAT3 inhibition (i.e. beyond astrocyte-specific gene deletion) provides robust protection not only against neuritic plaques and neuroinflammation, but also provides marked protection against vascular amyloid in the form of CAA and cerebrovascular dysfunction.